NCT03645109 is a NA clinical trial of Vitamin D3 in Vitamin D3, sponsored by Eva Elizabet Camarena Pulido.

Who is sponsoring NCT03645109?

NCT03645109 is sponsored by Eva Elizabet Camarena Pulido.

What drugs are being tested in NCT03645109?

Interventions in NCT03645109: Vitamin D3, Capsules with placebo (talcum food grade).

What condition does NCT03645109 study?

NCT03645109 studies Vitamin D3, Gestational Diabetes Mellitus in Pregnancy.

Is NCT03645109 still recruiting?

NCT03645109 is currently completed. Last updated 2 April 2021.

Last reviewed 2021-04-02 · How we verify

NCT03645109

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Suplementation of Vitamin D in Gestational Diabetes Mellitus

Completed NA Last updated 2 April 2021

What this trial tests

NA trial testing Vitamin D3 in Vitamin D3 in 50 participants. Completed in 10 March 2020.

Timeline

28 February 2020

Primary endpoint
28 February 2020

10 March 2020

Quick facts

Lead sponsor	Eva Elizabet Camarena Pulido
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	50
Start date	28 February 2020
Primary completion	28 February 2020
Estimated completion	10 March 2020
Sites	1 location across Mexico

Drugs / interventions tested

Vitamin D3 (cholecalciferol) — full drug profile →
Capsules with placebo (talcum food grade)

Conditions studied

Vitamin D3 — all drugs for Vitamin D3 →
Gestational Diabetes Mellitus in Pregnancy — all drugs for Gestational Diabetes Mellitus in Pregnancy →

Sponsor

Eva Elizabet Camarena Pulido

Who can join

Adults 18 to 40, female only, with Vitamin D3 or Gestational Diabetes Mellitus in Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized double-blind placebo-controlled clinical trial. Consists of the administration of 5,000 IU of vitamin D3 vs Placebo in patients with gestational diabetes mellitus during eight weeks. The objective is to analyze the effects of the intervention on the biochemical parameters that are part of the glycemic profile (insuline, HBA1c, glucose)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Vitamin D supplementation for women during pregnancy.
Palacios C, Kostiuk LL, Cuthbert A, Weeks J. · · 2024 · cited 21× · PMID 39077939 · DOI 10.1002/14651858.cd008873.pub5

Verify or expand the search:

Other trials of Vitamin D3

Trials testing the same drug.

NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
NCT07460336 — Effects of Cofrogliptin on Beta-Cell Function in LADA Patients · NA · not yet recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting
NCT07269223 — Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients · NA · recruiting
NCT07048860 — ICOPE INTENSE-K Pilot Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03645109 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eva Elizabet Camarena Pulido
Last refreshed: 2 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03645109.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing